Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI

This publication has 31 references indexed in Scilit:

• Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
  Human Reproduction Update, 2002
• The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome
  Human Reproduction, 2001
• Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial
  Human Reproduction, 2000
• Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
  Human Reproduction, 2000
• Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization
  Fertility and Sterility, 1999
• Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome
  Published by Wiley ,1993
• Reproductive endocrinologic alterations in female asymptomatic obesity
  Fertility and Sterility, 1989
• Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
  Diabetes, 1989
• Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*
  Journal of Clinical Endocrinology & Metabolism, 1987
• MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE
  The Lancet, 1985